Revenue & Margin TrendConsistent revenue growth paired with improving net profit and strong EBIT/EBITDA margins indicates sustainable operating performance. Over 2-6 months this suggests resilient product demand, scalable manufacturing economics and persistent ability to convert sales into operating profits for reinvestment.

Balance Sheet DisciplineA reasonable debt-to-equity mix with solid ROE reflects disciplined capital structure and efficient equity use. This durability supports funding of capex or working capital internally, reduces refinancing vulnerability and preserves financial flexibility across industry cycles.

Cash Generation ImprovementImproving free cash flow and healthy operating cash conversion show strengthening cash generation, enabling sustained capex, R&D or deleveraging. Over months this enhances the firm's ability to self-fund growth and absorb intermittent working-capital swings inherent in API manufacturing.

Bears Say

Earnings DeclineA negative EPS growth rate near -14.5% signals recent pressure on per-share profitability. Persisting EPS declines can limit retained earnings, constrain investment capacity, and indicate margin squeeze or episodic losses that could impair long-term dividend capacity and internal funding.

Gross Margin VolatilityVolatile gross margins point to inconsistent input costs, yields or pricing power in key API products. Over months this undermines predictability of profits, complicates long-term contracts and raises the risk that operating leverage may not reliably convert revenue growth into stable net income.

Reliance On LiabilitiesA moderate reliance on liabilities increases sensitivity to tighter credit conditions or margin contractions. Even with reasonable debt metrics today, elevated liabilities reduce cushion against shocks, raise refinancing risk and limit strategic optionality during prolonged industry stress periods.

SMS Lifesciences India Ltd. News

Haleos Labs Temporarily Withholds Dividends Pending KYC Updates

The latest update is out from SMS Lifesciences India Ltd. ( ($IN:SMSLIFE) ). Haleos Labs Limited, formerly known...

4M ago

Haleos Labs Opens Special Window for Share Transfer Requests

SMS Lifesciences India Ltd. ( ($IN:SMSLIFE) ) has shared an announcement. Haleos Labs Limited has announced the opening...

4M ago

SMS Lifesciences India Limited Announces Name Change at AGM

SMS Lifesciences India Ltd. ( ($IN:SMSLIFE) ) just unveiled an announcement. SMS Lifesciences India Limited, a company involved...

5M ago

SMS Lifesciences Announces Trading Window Closure Ahead of Financial Results

SMS Lifesciences India Ltd. ( ($IN:SMSLIFE) ) just unveiled an announcement. SMS Lifesciences India Ltd. has announced the...

5M ago

SMSLIFE FAQ

What was SMS Lifesciences India Ltd.’s price range in the past 12 months?

SMS Lifesciences India Ltd. lowest stock price was ₹956.05 and its highest was ₹1680.00 in the past 12 months.

What is SMS Lifesciences India Ltd.’s market cap?

SMS Lifesciences India Ltd.’s market cap is ₹4.10B.

When is SMS Lifesciences India Ltd.’s upcoming earnings report date?

SMS Lifesciences India Ltd.’s upcoming earnings report date is Jun 01, 2026 which is in 101 days.

How were SMS Lifesciences India Ltd.’s earnings last quarter?

SMS Lifesciences India Ltd. released its earnings results on Feb 11, 2026. The company reported ₹21.886 earnings per share for the quarter, beating the consensus estimate of N/A by ₹21.886.

Is SMS Lifesciences India Ltd. overvalued?

According to Wall Street analysts SMS Lifesciences India Ltd.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does SMS Lifesciences India Ltd. pay dividends?

SMS Lifesciences India Ltd. pays a Annually dividend of ₹1.5 which represents an annual dividend yield of 0.12%. See more information on SMS Lifesciences India Ltd. dividends here

What is SMS Lifesciences India Ltd.’s EPS estimate?

SMS Lifesciences India Ltd.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does SMS Lifesciences India Ltd. have?

SMS Lifesciences India Ltd. has 3,023,287 shares outstanding.

What happened to SMS Lifesciences India Ltd.’s price movement after its last earnings report?

SMS Lifesciences India Ltd. reported an EPS of ₹21.886 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -2.443%.

Which hedge fund is a major shareholder of SMS Lifesciences India Ltd.?

Currently, no hedge funds are holding shares in IN:SMSLIFE

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

SMS Lifesciences India Ltd.

SMS Lifesciences India Limited manufactures, buys, imports, and sells active pharmaceutical ingredients (API) and its intermediates, organic and inorganic chemicals, and pharmaceuticals in India. The company offers APIs in various therapeutic areas, such as antiulcer, antifungal, and erectile dysfunction. It also provides consultancy services. The company exports its products. The company was founded in 1990 and is based in Hyderabad, India.